Catalase deficiency may complicate urate oxidase (rasburicase) therapy

Free Radical Research

Volumn 41, Issue 9, 2007, Pages 953-955

  Góth, László ^a   Bigler, N William ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Blood catalase; Catalase deficiency; Haemolysis; Tumour lysis syndrome; Urate acid oxidase treatment

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC AGENT; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; METHEMOGLOBIN; RASBURICASE; URATE OXIDASE;

CATALASE DEFICIENCY; CLINICAL TRIAL; CYTOLYSIS; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FAMILIAL DISEASE; GENE FREQUENCY; GEOGRAPHIC DISTRIBUTION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HEMOLYTIC ANEMIA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERURICEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPIDOSIS; METHEMOGLOBINEMIA; NOTE; OXIDATIVE STRESS; RISK ASSESSMENT; SIDE EFFECT; TUMOR LYSIS SYNDROME;

ACATALASIA; CATALASE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMANS; HYDROGEN PEROXIDE; METHEMOGLOBINEMIA; TUMOR LYSIS SYNDROME; URATE OXIDASE;

EID: 34548348331     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701482451     Document Type: Note

References (29)

1. Jeha, S. (2001) Tumor lysis syndrome. Semin Hematol, 38, pp. 4-8.
2. Pui, CH. (2001) Urate oxidase in the prophylaxis or treatment of hyperuricemia. Semin Hematol, 38, pp. 13-21.
3. Rampello, E., Fricia, T. and Malaguarnera, M. (2006) The management of tumor lysis syndrome. Nature Clin Prac Oncol, 3, pp. 438-447.
4. Oldfield, V. and Perry, CM (2006) Rasburicase - A review of its use in the management of anticancer therapy-induced hyperuricaemia. Drugs, 66, pp. 529-545.
5. Sood, AR, Burry, LD, Cheng, DKE and Doret, KE (2007) Clarifying the role of rasburicase in tumor lysis syndrome. Pharamacotherapy, 27, pp. 111-121.
6. Coiffier, B. and Riouffol, C. (2007) Management of tumor lysis syndrome in adults. Expert Rev Anticancer Ther, 7, pp. 233-239.
7. Wang, LY, Shih, LY, Hung, C., Jou, ST, Lin, KH, Yeh, TC, Lin, SF and Liang, DC (2006) Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies. Acta Haematol, 115, pp. 35-38.
8. McNutt, DM, Holdsworth, MT, Wong, C., Hanrahan, JD and Winter, SS (2006) Rasburicase for the management of tumor lysis syndrome in neonates. Ann Pharmacother, 40, pp. 1445-1450.
9. Moolenburgh, JD, Reinders, MK and Jansen, TLTA (2006) Rasburicase treatment in severe tophaceous gout: A novel therapeutic option. Clin Rheumatol, 25, pp. 749-752.
10. Gaetani, GF, Ferraris, AM, Rolfo, H., Mangerini, R., Arena, S. and Kirkman, H. (1966) Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood, 87, pp. 1595-1599.
11. 2 removing enzyme in human erythrocytes. Blood, 90, pp. 4973-4979.
12. Patte, C., Sakiroglu, C., Ansoborlo, S., Baruchel, A., Plouvier, E., Pacquement, H. and Babin-Boilletot, A. (2002) Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol. Ann Oncol, 13, pp. 789-795.
13. Wossmann, W., Schrappe, M., Meyer, U., Zimmermann, M. and Reiter, A. (2003) Incidence of tumor lysis syndrome in children with advanced stage Burkit's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol, 82, pp. 160-165.
14. Backsgaard, L. and Sorensen, JB. (2003) Acute tumor lysis syndrome in solid tumors - a case report and review of literature. Cancer Chemother Pharmacol, 51, pp. 187-192.
15. Browning, LA and Kruse, JA. (2005) Hemolysis and methemoglobinemia secondary to rasburicase administration. Ann Pharmacother, 39, pp. 1932-1935.
16. Oldfield, V. and Perry, CM. (2006) Spotlight on rasburicase in anticancer therapy-induced hyperuricemia. Biodrugs, 20, pp. 197-199.
17. Masuoka, N., Wakimoto, M., Ubuka, T. and Nakano, T. (1996) Spectrophotometric determination of hydrogen peroxide: Catalase activity and rates of hydrogen peroxide removal by erythrocytes. Clin Chim Acta, 254, pp. 101-112.
18. Jacob, HS, Ingbar, SH and Jandl, JH. (1965) Oxidative hemolysis and erythrocyte metabolism in hereditary acatalasemia. J Clin Invest, 44, pp. 1187-1199.
19. Gaetani, GF, Rolfo, H., Arena, S., Mangerini, R., Meloni, GF and Ferraris, AM. (1996) Active involvement of catalase during hemolytic crisis of favism. Blood, 88, pp. 1084-1088.
20. Halliwell, B., Clement, MV and Long, LH. (2000) Hydrogen peroxide in the human body. FEBBS Letts, 486, pp. 10-13.
21. Góth, L. (1989) Origin of serum catalase in healthy subjects and in some hematologic diseases. Clin Chem Enzymol Comms, 1, pp. 329-331.
22. Góth, L. (2000) A new type of inherited catalase deficiency: Its characterization and comparison to the Japanese and Swiss types of acatalasemia. Blood Cells Mol Dis, 27, pp. 512-517.
23. Góth, L. and Eaton, JW. (2000) Hereditary catalase deficiencies and increased risk of diabetes. Lancet, 356, pp. 1820-1821.
24. Góth, L. (2000) Lipid and carbohydrate metabolism in acatalasemia. Clin Chem, 46, pp. 564-566.
25. Góth, L. and Vitai, M. (1995) Hungarian hereditary acatalasemian and hypocatalasemia are not associated with chronic hemolysis. Clin Chim Acta, 233, pp. 75-79.
26. Hamada, Y., Kameyama, Y., Izuka, T., Ishizaki, T., Nishiyama, T. and Isshiki, A. (2004) Methemoglobinemia from hydrogen peroxide in a patient with acatalasemia. Anesthesiology, 101, pp. 247-248.
27. Kizer, N., Martinez, E. and Powell, M. (2006) Report of two cases of rasburicase-induced methemoglobinemia. Leuk Lymphoma, 47, pp. 2648-2650.
28. Arndt, B. (1996) Hypocatalasemia in hospital patients. Clin Lab, 42, p. 801.
29. Aebi, H., Bossi, E., Cantz, M., Matsubara, S. and Suter, H. (1968) Acatalas(em)ia in Switzerland. Hereditary disorders of erythrocyte metabolism, pp. 41-61. Grune and Straton, New York